Valvular & structural heart disease

Right Atrial Remodelling and Prognosis in Patients with Severe Atrial Functional Tricuspid Regurgitation

ESC Heart FailPublished retrospective study

Authors' conclusion

RA and RV enlargement are poor prognostic factors in patients with severe AFTR. These findings underscore the importance of assessing RA and RV remodelling to optimize the timing of intervention in this population.

Study context

Population
Patients with severe atrial functional tricuspid regurgitation (AFTR)patients with severe AFTR, 96.1% of whom had atrial fibrillation
Participants
155 patients
Exposure
Medical management group vs surgical intervention group
  • Medical management groupn = 121
  • Surgical intervention groupn = 34
Outcome
All-cause mortality
Follow-up
Median of 3.3 years
Methodological detailsconsecutive patients
  • Consecutive patients

Main finding

As reported in the abstract

Medical management group

34.7%

42 of 121

Cox analysis, medical management group
Adjusted hazard ratio (95% CI)P value
RV end-diastolic area index, per 1 cm²/m² increase
1.11(1.02–1.22)
P = 0.019
RA area index, per 1 cm²/m² increase
1.06(1.02–1.10)
P = 0.006

Per 1 cm²/m² increase, as printed

Lower survival with RV end-diastolic area index >14.5 cm²/m² vs counterparts
P = 0.012
Lower survival with RA area index >22 cm²/m² vs counterparts
P = 0.001
Mortality highest with both high RV end-diastolic area index (>14.5 cm²/m²) and RA area index (>22 cm²/m²), lowest with low values for both
P = 0.001

Observational data: associations, not effects.

Further findings

Post-surgical deaths — surgical intervention group
11.8%

Post-surgical deaths

Occurred exclusively in patients with both high RA area and RV end-diastolic area indices

Original publication

Right Atrial Remodelling and Prognosis in Patients with Severe Atrial Functional Tricuspid Regurgitation. ESC Heart Fail. Published 16 April 2025. doi:10.1002/ehf2.15301

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.